We postulate that cytotoxic CD4+ T cells exist in NSCLC and may function via HLA-II expression on tumor cells32,33, which, when viewed collectively, could be a mechanistic basis for anti-tumor immune responses observed in HLA-I-disrupted tumors. The gene discussed is CD4; the disease is non-small cell lung carcinoma.